LDX 4.26% 4.9¢ lumos diagnostics holdings limited

Ann: Lumos Files Appeal To The FDA For FebriDx, page-2

  1. 3,244 Posts.
    lightbulb Created with Sketch. 313
    'At this time, there is no rapid, point-of-care test available in the US that clinicians can use to help distinguish a bacterial respiratory infection from a viral infection.'

    That is the key takeaway.

    This will be so huge if Lumos can get the FDA approval. Fingers crossed.
 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
(20min delay)
Last
4.9¢
Change
0.002(4.26%)
Mkt cap ! $23.58M
Open High Low Value Volume
4.7¢ 5.0¢ 4.7¢ $126.6K 2.639M

Buyers (Bids)

No. Vol. Price($)
1 25000 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 199806 1
View Market Depth
Last trade - 11.12am 24/07/2024 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.